Journal Information
Vol. 14. Issue 5.
Pages 495-501 (September - October 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 5.
Pages 495-501 (September - October 2010)
Original article
Open Access
HIV subtype, epidemiological and mutational correlations in patients from Paraná, Brazil
Visits
2250
Monica Maria Gomes da Silva1,
Corresponding author
monica.mgomes@gmail.com

Correspondence to: Rua Lindolfo Pessoa 230/303 Curitiba, Paraná, Brazil. CEP: 80240-330.
, Flavio Queiroz Telles2, Clovis Arns da Cunha3, Frank S. Rhame4
1 Infectious Diseases and Neurology Specialist - Infectious Diseases Department at Hospital Nossa Senhora das Graças, Curitiba, Paraná
2 Hospital de Clinicas da Universidade Federal do Paraná Professor at Universidade Federal do Paraná - Clinical Director of Hospital de Clínicas da Universidade Federal do Paraná
3 Clinical Fellow at University of Minnesota Professor at Universidade Federal do Paraná - Director of Infectious Diseases Department at Hospital Nossa Senhora das Graças, Paraná
4 Adjunct Professor, Div of Infectious Diseases, Dept of Medicine, University of Minnesota Associate Adjunct Professor, Div of Epidemiology, School of Public Health, University of Minnesota Research Director, Clinic 42, Abbott Northwestern Hospital Physician, Allina Medical Clinic
This item has received

Under a Creative Commons license
Article information
Abstract
Objective

Analyze patients with HIV infection from Curitiba, Paraná, their epidemiological characteristics and HIV RAM.

Methods

Patients regularly followed in an ID Clinic had their medical data evaluated and cases of virological failure were analyzed with genotypic report.

Results

Patients with complete medical charts were selected (n = 191). Demographic and clinical characteristics were compared. One hundred thirty two patients presented with subtype B infection (69.1%), 41 subtype C (21.5%), 10 subtype F (5.2%), 7 BF (3.7%) and 1 CF (0.5%). Patients with subtype B infection had been diagnosed earlier than patients with subtype non-B. Also, subtype B infection was more frequent in men who have sex with men, while non-B subtypes occurred more frequently in heterosexuals and women. Patients with previous history of three classes of ARVs (n = 161) intake were selected to evaluate resistance. For RT inhibitors, 41L and 210W were more frequently observed in subtype B than in non-B strains. No differences between subtypes and mutations were observed to NNTRIs. Mutations at 10, 32 and 63 position of protease were more observed in subtype B viruses than non-B, while positions 20 and 36 of showed more amino acid substitutions in subtype non-B viruses. Patients with history of NFV intake were evaluated to resistance pathway. The 90M pathway was more frequent in subtypes B and non-B. Mutations previously reported as common in non-B viruses, such as 65R and 106M, were uncommon in our study. Mutations 63P and 36I, previously reported as common in HIV-1 subtypes B and C from Brazil, respectively, were common.

Conclusion

There is a significant frequency of HIV-1 non-B infections in Paraná state, with isolates classified as subtypes C, F, BF and BC. Patients with subtype C infection were more frequently female, heterosexual and had a longer average time of HIV diagnosis.

Keywords:
HIV
aids
subtypes
subtype B
subtype non-B
genetic diversity
antiretroviral
Brazil
Full text is only aviable in PDF
References
[1.]
HIV Databasis, accessed at http://www.hiv.lanl.gov/content/index, on Oct, 2009.
[2.]
J. Hemelaar, E. Gouws, P.D. Ghys, S. Osmanov.
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.
[3.]
Brazilian Minister of Health. Boletim Epidemiologico ano V no 1. 2008 avaiable at www.aids.gov.br.
[4.]
C.C. Barreto, A. Nischyia, L.V. Araujo, J.E. Ferreira, M.P. Busch, E.C. Sabino.
Trends in Antiretroviral Drug Resistance and Clade Distributions among HIV-1-infected Blood Donors in São Paulo, Brazil.
J Acquir Immune Defic Syndr, 41 (2006), pp. 338-341
[5.]
A.M.B. Martinez, E.F. Barbosa, P.C.P. Ferreira, et al.
Molecular Epidemiology of HIV-1 in Rio Grande, RS, Brazil.
Rev Soc Med Trop, 35 (2002), pp. 471-476
[6.]
D. Locatelli, P.H. Stoco, A.T. De Queiroz, et al.
Molecular Epidemiology of HIV-1 in Santa Catarina State confirms increases of Subtype C in Southern Brazil.
J Med Virol, 79 (2007), pp. 1455-1463
[7.]
J.R. Marins, L.F. Jamal, S.Y. Chen, et al.
Dramatic improvement in survival among adult Brazilian AIDS patients.
[8.]
V.A. Johnson, F. Brun-Vezinet, B. Clotet, et al.
Update of the Drug Resistance Mutations in HIV-1: December 2008.
Topics in Medicine, 16 (2008), pp. 138-144
[9.]
A. Deshpande, V. Jauvin, N. Magnin, et al.
Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to ARV.
AIDS Res Hum Retroviruses, 23 (2007), pp. 335-340
[10.]
F. Doualla-Bell, A. Avalos, B. Brenner, et al.
High prevalence of K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.
Antimicrob Agents Chemother, 50 (2006), pp. 4182-4185
[11.]
J.C. Couto-Fernandez, M.G. Morgado, V. Bongertz, et al.
HIV-1 subtyping in Salvador, Bahia, Brazil: a city with African sociodemographic characteristics.
J Acquir Immune Defic Syndr, 22 (1999), pp. 288-293
[12.]
E.A.J.M. Soares, R.P. Santos, J.A. Pellegrini, E. Sprinz, A. Tanuri, M.A. Soares, Epidemiologic.
Molecular Characterization of Human Immunodeficiency Virus Type 1 in Souther Brazil.
J Acquir Immune Defic Syndr, 34 (2003), pp. 520-526
[13.]
E.A. Soares, A.M. Martinez, T.M. Souza, A.F. Santos, V.D. Hora.
HIV-1 Subtype C dissemination in Southern Brazil.
AIDS, 19 (2005), pp. S81-S86
[14.]
A.S. Soares, T. De Oliveira, R.M. Brindeiro, et al.
A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil.
[15.]
J. Fox, A. Dudaz, H. Green.
Epidemiology of non-B clade forms of HIV-1 in MSM in the UK [poster 117].
Program and abstracts of the 13th Annual Conference of the British HIV Association (Edinburgh, Scotland),
[16.]
A.M. Geretti, L. Harrison, H. Green, et al.
UK Collaborative Group on HIV Drug Resistance. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.
Clin Infect Dis, 48 (2009), pp. 1296-1305
[17.]
B.L. Walter, A.E. Armitage, S.C. Graham, et al.
Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility.
[18.]
R.W. Shafer, J.M. Schapiro.
HIV-1 Drug Resistance Mutations: un Update Framework for the Second Decade of HAART.
AIDS Rev, 10 (2008), pp. 67-84
[19.]
Brazilian Minister of Health 2008. Recomendações para Tratamento de Adultos Infectados pelo HIV. Avaiable at www.aids.gov.br.
[20.]
V. Novitsky, C.W. Wester, V. DeGruttola, et al.
The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1 C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.
AIDS Res Hum Retroviruses, 23 (2003), pp. 868-878
[21.]
Z. Grossman, V. Istomin, D. Averbuch, et al.
Genetic Variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.
AIDS, 18 (2004), pp. 909-915
[22.]
E.A.J.M. Soares, A.F.A. Santos, T.M. Sousa, et al.
Differencial Drug Resistance Acquisition in HIV-1 of Subtypes B and C.
PLoS One, 8 (2007), pp. 1-8
[23.]
D. Coutsinos, C.F. Invernizzi, H. Xu, et al.
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.
J Virol, 83 (2009), pp. 2029-2033
[24.]
H. Sunpath, H. France, M. Tarin, et al.
Prospective analysis of HIV-1 Drug Resistance After Virologic Failure on Antiretroviral Therapy (ART): Initial Results from a Paediatric Cohort Study from KZN, South Africa.
15th Conference on Retrovirus and Opportunistic Infections,
[25.]
S. Sen, S.P. Tripathy, A.A. Patil, V.M. Chimanpure, R.S. Paranjape.
High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India.
AIDS Res Hum Retroviruses, 23 (2007), pp. 1303-1308
[26.]
B. Brenner, D. Turner, M. Oliveira, et al.
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers crossresistance to non-nucleoside reverse transcriptase inhibitors.
[27.]
R. Kantor, D.A. Katzenstein, B. Efron, et al.
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
[28.]
C. Perno, F. Cozzi-Lepri, A. Forbici.
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients whom their first PI antiretroviral regimen failed.
J Infect Dis, 189 (2004), pp. 1983-1987
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools